Duffy Timothy M

Avg. Two Year Performance

No purchase track record
59% Avg. Sale Return
26% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return1%(3%)(11%)9%59%
Sale Success Rate1 of 31 of 31 of 31 of 33 of 3

Adhera Therapeutics, Inc.

Drugs » Biotechnology

Chief Business Officer:

Holdings: 56.4K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--